SHORTER HOSPITAL STAYS AND OUTCOMES AFTER NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION  by Rymer, Jennifer et al.
A42
JACC April 1, 2014
Volume 63, Issue 12
Acute Coronary Syndromes
Shorter hoSpital StayS and outComeS aFter non-St-Segment elevation myoCardial 
inFarCtion
Poster Contributions
Hall C
Saturday, March 29, 2014, 10:00 a.m.-10:45 a.m.
Session Title: Acute Coronary Syndromes: NSTEMI
Abstract Category: 1. Acute Coronary Syndromes: Clinical
Presentation Number: 1117-219
Authors: Jennifer Rymer, Michael Tempelhof, Robert Clare, Karen Pieper, Renato Lopes, Christopher Granger, Frans Van De Werf, David Moliterno, 
Robert Harrington, Harvey White, Paul Armstrong, Robert Califf, Kenneth Mahaffey, L. Kristin Newby, Duke University Medical Center, Durham, 
NC, USA
Hospital length of stay (LOS) after non-ST-segment elevation myocardial infarction (NSTEMI) continues to decrease, but limited data exist to support 
this trend.
We examined associations between hospital LOS and outcomes among 20,410 NSTEMI patients enrolled in 5 clinical trials of acute antithrombotic 
therapy. Uncomplicated NSTEMI was defined as the absence of in-hospital death, recurrent MI or ischemia, heart failure, stroke or coronary artery 
bypass grafting (CABG) surgery. We evaluated adjusted associations between LOS and 1-y death, 6-m death and death/MI and 30-d death/MI.
Median LOS was 7 (4, 12) days. 1,322 uncomplicated patients (6.5%) were discharged during hospital days 0-2. Of 15,879 uncomplicated patients 
(77.8%) from days 0-2 who remained hospitalized on day 3, 13,126 (82.6%) remained hospitalized and uncomplicated from days 3-7. Among 
uncomplicated patients hospitalized on day 3, those with complications (n=2,753) before day 7 were older (67 vs 65 y), more often had diabetes 
(27.8% vs 23.7%) and ST-segment depression on admission (58.2% vs 50.7%) than those remaining uncomplicated. Adjusted event-free survival 
rates (95% CI) by discharge day for uncomplicated patients are in Table 1.
Uncomplicated NSTEMI patients during the first 2 hospital days were at low risk of short- and intermediate-term death or ischemic events. Other 
factors may drive LOS; however, these data suggest that discharge after 2 days is reasonable and might reduce costs for many uncomplicated 
NSTEMI patients.
 
